Literature DB >> 16752109

Medicaid coverage and access to publicly funded opiate treatment.

Dennis D Deck1, Wyndy L Wiitala, Katherine E Laws.   

Abstract

This observational study examines changes in access to methadone maintenance treatment following Oregon's decision to remove substance abuse treatment from the Medicaid benefit for an expansion population. Access was compared before and after the benefit change for two cohorts of adults addicted to opiates presenting for publicly funded treatment. Propensity score analysis helped model some selective disenrollment from Medicaid that occurred after the benefit change. Logistic regression was used to compare access to methadone by cohort controlling for client characteristics. Opiate users presenting for publicly funded treatment after the change were less than half as likely (OR = 0.40) to be placed in an opiate treatment program compared to the prior year. Further analysis revealed that those with no recent treatment history were less likely to present for treatment after the benefit change. These results have implications for states considering Medicaid cuts, especially if the anticipated increases in illegal activity, emergency room utilization, unemployment, and mortality can be demonstrated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16752109     DOI: 10.1007/s11414-006-9018-2

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.505


  19 in total

1.  HIV transmission and the cost-effectiveness of methadone maintenance.

Authors:  G S Zaric; P G Barnett; M L Brandeau
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

2.  Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus.

Authors:  N G Shah; D D Celentano; D Vlahov; V Stambolis; L Johnson; K E Nelson; S A Strathdee
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

3.  Changes in health insurance and payment for substance use treatment.

Authors:  Jean Oggins
Journal:  Am J Drug Alcohol Abuse       Date:  2003       Impact factor: 3.829

4.  Access to publicly funded methadone maintenance treatment in two western states.

Authors:  Dennis Deck; Matthew J Carlson
Journal:  J Behav Health Serv Res       Date:  2004 Apr-Jun       Impact factor: 1.505

5.  Can syringe exchange serve as a conduit to substance abuse treatment?

Authors:  R Heimer
Journal:  J Subst Abuse Treat       Date:  1998 May-Jun

Review 6.  Treatment as harm reduction, defunding as harm maximization: the case of methadone maintenance.

Authors:  M Rosenbaum; A Washburn; K Knight; M Kelley; J Irwin
Journal:  J Psychoactive Drugs       Date:  1996 Jul-Sep

7.  Revisiting the behavioral model and access to medical care: does it matter?

Authors:  R M Andersen
Journal:  J Health Soc Behav       Date:  1995-03

8.  Methadone maintenance and state Medicaid managed care programs.

Authors:  D McCarty; R G Frank; G C Denmead
Journal:  Milbank Q       Date:  1999       Impact factor: 4.911

9.  Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.

Authors:  Carmen L Masson; Paul G Barnett; Karen L Sees; Kevin L Delucchi; Amy Rosen; Wynnie Wong; Sharon M Hall
Journal:  Addiction       Date:  2004-06       Impact factor: 6.526

Review 10.  Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction.

Authors: 
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272

View more
  8 in total

1.  Factors related to Medicaid payment acceptance at outpatient substance abuse treatment programs.

Authors:  Yvonne M Terry-McElrath; Jamie F Chriqui; Duane C McBride
Journal:  Health Serv Res       Date:  2010-11-24       Impact factor: 3.402

Review 2.  Using administrative data for longitudinal substance abuse research.

Authors:  Elizabeth Evans; Christine E Grella; Debra A Murphy; Yih-Ing Hser
Journal:  J Behav Health Serv Res       Date:  2008-08-05       Impact factor: 1.505

3.  State variations in Medicaid enrollment and utilization of substance use services: Results from a National Longitudinal Study.

Authors:  Ramin Mojtabai; Kenneth A Feder; Marc Kealhofer; Noa Krawczyk; Carla Storr; Kayla N Tormohlen; Andrea S Young; Mark Olfson; Rosa M Crum
Journal:  J Subst Abuse Treat       Date:  2018-04-04

4.  Effect of eliminating behavioral health benefits for selected medicaid enrollees.

Authors:  K John McConnell; Neal T Wallace; Charles A Gallia; Jeanene A Smith
Journal:  Health Serv Res       Date:  2008-04-01       Impact factor: 3.402

5.  Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications.

Authors:  Colleen M Grogan; Christina Andrews; Amanda Abraham; Keith Humphreys; Harold A Pollack; Bikki Tran Smith; Peter D Friedmann
Journal:  Health Aff (Millwood)       Date:  2016-12-01       Impact factor: 6.301

Review 6.  The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.

Authors:  Amanda I Mauri; Tarlise N Townsend; Rebecca L Haffajee
Journal:  Milbank Q       Date:  2019-12-04       Impact factor: 4.911

7.  Medicaid coverage, methadone maintenance, and felony arrests: outcomes of opiate treatment in two states.

Authors:  Dennis Deck; Wyndy Wiitala; Bentson McFarland; Kevin Campbell; John Mullooly; Antoinette Krupski; Dennis McCarty
Journal:  J Addict Dis       Date:  2009

8.  Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.

Authors:  Rachel M Burns; Rosalie L Pacula; Sebastian Bauhoff; Adam J Gordon; Hollie Hendrikson; Douglas L Leslie; Bradley D Stein
Journal:  Subst Abus       Date:  2015-11-13       Impact factor: 3.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.